ExodusPoint Capital Management, LP

Position in HROW — Harrow, Inc.

CIK 1736225 NEW YORK, NY

Back to HROW Full portfolio

Position in HROW

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,029,600

+$345,734 QoQ

Shares Held

24,243

+70.8% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#78

of 223 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names. HROW ranks #10 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	150,033	$16,644,661
2	ELAN	Elanco Animal Health Inc	446,179	$10,980,465
3	BCRX	Biocryst Pharmaceuticals Inc	744,917	$7,449,170
4	AMRX	Amneal Pharmaceuticals, Inc.	256,843	$4,445,952
5	ANIP	Ani Pharmaceuticals Inc	32,838	$2,718,329
6	KNSA	Kiniksa Pharmaceuticals International, plc	33,017	$2,111,437
7	INDV	Indivior Pharmaceuticals, Inc.	49,984	$2,050,843
8	ALKS	Alkermes plc.	31,684	$1,660,241

All Filings in HROW

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,029,600	24,243	+70.8%	Shares	Sole	2026-08-14
2025-09-30	$683,866	14,194	-54.9%	Shares	Sole	2025-11-14
2024-12-31	$1,055,046	31,447	-48.5%	Shares	Sole	2025-02-12
2024-03-31	$808,353	61,100	+510.3%	Shares	Sole	2024-05-14
2023-12-31	$112,123	10,011	-70.6%	Shares	Sole	2024-02-14
2023-09-30	$490,002	34,099	+205.9%	Shares	Other	2023-11-13
2021-09-30	$101,326	11,147	-77.2%	Shares	Sole	2021-11-15
2021-06-30	$454,392	48,912	+65.2%	Shares	Sole	2021-08-16
2020-03-31	$113,075	29,601	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.